Navigation Links
Novel Cooling Therapy May Have Aided Injured Football Player
Date:9/13/2007

Lowering Kevin Everett's body temperature helped protect his spinal cord, doctors say

THURSDAY, Sept. 13 (HealthDay News) -- As Buffalo Bills football player Kevin Everett was being rushed by ambulance to a hospital Sunday night with a life-threatening spinal cord injury, he was already getting experimental treatment that may have saved him from paralysis.

Everett's spinal cord was damaged in his neck as he tried to tackle Denver Bronco Domenik Hixon during the Bills' season opener. Everett dropped face-first to the turf after his helmet hit Hixon on the left shoulder.

In the ambulance to Buffalo's Millard Fillmore Gates Hospital, a doctor injected Everett with steroids -- standard treatment to reduce swelling and potentially damaging inflammation. But, at the same time, paramedics started pumping an ice-cold saline solution into Everett's veins, to lower his body temperature, according to news reports. The approach, though experimental, has shown promise in stroke and cardiac arrest patients, and even in infants deprived of oxygen.

The theory behind the therapy: By lowering the core body temperature between six and eight degrees, doctors can tamp down swelling and inflammation, and limit the release of harmful chemicals -- such as free radicals -- that can cause even more damage than that left by the initial injury.

Still, Everett's prognosis on Sunday was dim. Once at the hospital, however, the body-cooling efforts -- called moderate hypothermia -- were continued using an external system as well as intravenous saline that reduced his core body temperature by 8 to 10 degrees, according to published reports.

"The advantage of cooling is that it is a neuro-protective agent that is able to attenuate [limit] the amount of injury that occurs after a spinal injury," said Dr. David Greer, an instructor in neurology at Massachusetts General Hospital. "It decreases the amount of injury and the swellin
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Gene enchances radiation therapy - A novel approach to fight cancer
3. A novel augmentation
4. Novel biopsy technique for prostate cancer
5. Novel computer model for breast cancer
6. Novel research on liver cancer
7. Novel way to fight cancer
8. Novel test for bowel cancer
9. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
10. Novel Therapy for Chronic Problem
11. Blood Sugar Kept In Control By Novel Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...r Tom Torlakson Introduces AB 89 , , SACRAMENTO...y, Lung Cancer Alliance-California (LCA-CA), haile... District) for his continued leadership in introdu... research. For the third consecutive year, legisl...g considered in the California Legislature. , ...
(Date:1/8/2009)...olesterol more effectively than Zocor , ,...y a year of review, U.S. health officials said Thu... controversial cholesterol-lowering drug Vytorin. ...ere was no significant difference in carotid arter...tients taking the drug Zocor. , But, the agency...
(Date:1/8/2009)...on in 2009 Continues Growth Trend , , NORTH HOL...PC The Hospitalist Company, Inc. (Nasdaq: IPCM )...ractice company, announced today that it has acqui... Consultants, Inc. (MACC) in St. Louis, Missouri. ...the St. Louis market, where IPC has established a ...
(Date:1/8/2009)...ssing traditional risk factors, experts say , ...olecular signs -- or "biomarkers" -- of inflammati...ssess a person,s risk of stroke, new research says...ing these markers does not change things much," sa...st at the Methodist DeBakey Heart & Vascular C...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3
...e symptoms like forgetting, distracted, impulsive ... University Medical Center// investigates whether ...Disorders (ADHD) are causing people to smoke. If...HD combined with the standard treatment to help pe...
...ned in how to handle severe allergic reactions, AM...he AMA is calling on all State and Territory Gover...for people who work with children,' Dr Haikerwal s... cover appropriate first aid for anaphylactic shoc...
...y the State government that legal notices have bee...he State of Maharashtra. Following a case of negli...t a fraudulent doctor by a Govandi resident, Maria...ollowing medical negligence while under the treatm...
...because of the blood-brain barrier, which prevents...loodstream into the brain. In order for chemothera...r. 'Thinking outside the box is a must for develo...n't get into the brain when delivered in the norma...
Other Medicine News:Health News:A New Study To Examine ADHD's Role In Smoking 2Health News:Nanoparticles Used by Researchers to Attack Brain Tumours 2
(Date:1/6/2009)...re-FirstCall/ -- , - Early Renewal of the A...er 2011 , - Expansion of the Scope of the C...thalmology , - Revised Commercial Terms and... Third Party , ExonHit Therapeutics (Alte...its existing drug discovery collaboration with All...
(Date:1/5/2009)...FirstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a...ietary,antibodies for the treatment of cancer, in...utlook on key events anticipated for the year 2009... on its research and development,programs at the ...: Update on several preclinical BiTE antibodies at...
(Date:1/3/2009)...Ill., Jan. 2 Magnetic r...viding an increasing number of clinical benefits w...to an article in the January 2009 issue of the Jou...ns ( http://www.jaaos.org/ ). It is predicted tha...l developments will allow MRI to provide even more...
(Date:12/29/2008)...ewswire/ -- The winner of the 2008 Award for Excel...oday by Dr. Peter G. Goldschmidt, President and Fo... The winner of the annual award was the Univers... its best practice " IND Regulatory and Monitoring...human subjects protection, 2) improved data qualit...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 32008 Human Research Protection Award Recipients Announced 2New nanostructured thin film shows promise for efficient solar energy conversion 2511 1New nanostructured thin film shows promise for efficient solar energy conversion 2511 2New nanostructured thin film shows promise for efficient solar energy conversion 2511 3Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 1Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 2Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 3Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 4Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 5Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 6AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 9280 1AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 9280 2Round Table Family Charities Raises 24350 000 for Childrens Miracle Network 9276 1Round Table Family Charities Raises 24350 000 for Childrens Miracle Network 9276 2
...-- Shire plc,announced today the positive results ...acine extended release (GXR,previously referred t...onist. These data from two short-term phase,III pl...II,open-label studies, presented at the 2007 Ameri...demonstrated that GXR,significantly improved all c...
...onoclonal Antibody,Targeting Interleukin-9 (IL-9);...-9 Inhibition in Developing Potential Asthma,Thera...FirstCall/ --,MedImmune, Inc. today announced the ...within the company,s inflammatory,disease pipeline...ies with its monoclonal antibody (MAb) targeting I...
Other Medicine Technology:Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: